PD

Payal Divyangbhai Virpara

Active Director Designated Partner DIN 11072238
DIN 11072238 First appointment Apr 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Payal Divyangbhai Virpara

Data last updated:

Payal Divyangbhai Virpara is a Designated Partner at Rudraay Pharmaceuticals Llp (since 2025). The company operates in Pharma.

DIN 11072238
Primary Designation Designated Partner
Industry Pharma
First Appointment 24 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner24 Apr 20252025Active

Board colleagues of Payal Divyangbhai Virpara

NameDINCompanyDesignation
Rekhaben Dharmendrakumar Teraiya11072237Rudraay Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Rudraay Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Payal Divyangbhai Virpara

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Payal Divyangbhai Virpara

Payal Divyangbhai Virpara currently holds 1 directorship: Rudraay Pharmaceuticals Llp (Designated Partner, since 24 Apr 2025).

Payal Divyangbhai Virpara was first appointed on 24 Apr 2025 as Designated Partner at Rudraay Pharmaceuticals Llp.

The current boards of Payal Divyangbhai Virpara's companies include Rekhaben Dharmendrakumar Teraiya (Rudraay Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available